Latest & greatest articles for dementia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on dementia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on dementia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for dementia

601. Antipsychotics for behavioural and psychological problems in elderly people with dementia: a systematic review of adverse events

Antipsychotics for behavioural and psychological problems in elderly people with dementia: a systematic review of adverse events Antipsychotics for behavioural and psychological problems in elderly people with dementia: a systematic review of adverse events Antipsychotics for behavioural and psychological problems in elderly people with dementia: a systematic review of adverse events van Iersel MB, Zuidema SU, Koopmans RT, Verhey FR, Rikkert MG CRD summary This review concluded (...) that there was a need for better reporting of harms in randomised controlled trials of antipsychotics for behavioural and psychological symptoms of dementia. This conclusion appears appropriate given the evidence presented. Authors' objectives To evaluate adverse events in relation to antipsychotic medications for behavioural and psychological symptoms of dementia Searching MEDLINE, EMBASE, PsycINFO and Cochrane Central Register of Controlled Trials (CENTRAL) were searched up to 2005. Search terms were reported

2005 DARE.

602. A review of studies describing the use of acetyl cholinesterase inhibitors in Parkinson's disease dementia Full Text available with Trip Pro

A review of studies describing the use of acetyl cholinesterase inhibitors in Parkinson's disease dementia A review of studies describing the use of acetyl cholinesterase inhibitors in Parkinson's disease dementia A review of studies describing the use of acetyl cholinesterase inhibitors in Parkinson's disease dementia Maidment I D, Fox C, Boustani M CRD summary This review assessed acetyl cholinesterase inhibitors for Parkinson's disease dementia. The authors concluded that cholinesterase (...) inhibitors have a modest effect on cognitive symptoms but little effect on neuropsychiatric symptoms, and poor tolerability may limit their utility. The lack of a description of the review methods and the use of multiple outcomes make it difficult to comment on the reliability of the conclusions. Authors' objectives To assess the effects of acetyl cholinesterase inhibitors in patients with Parkinson's disease dementia (PDD). Searching MEDLINE, PsycINFO, EMBASE and CINAHL (all from inception to December

2005 DARE.

603. The effects of psychosocial methods on depressed, aggressive and apathetic behaviors of people with dementia: a systematic review

The effects of psychosocial methods on depressed, aggressive and apathetic behaviors of people with dementia: a systematic review Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2005 DARE.

604. A systematic review of the scientific evidence for the efficacy of a palliative care approach in advanced dementia

A systematic review of the scientific evidence for the efficacy of a palliative care approach in advanced dementia A systematic review of the scientific evidence for the efficacy of a palliative care approach in advanced dementia A systematic review of the scientific evidence for the efficacy of a palliative care approach in advanced dementia Sampson E L, Ritchie C W, Lai R, Raven P W, Blanchard M R CRD summary This review assessed the efficacy of palliative care models in patients (...) with dementia. The authors concluded that there is currently little evidence on which to base any conclusions. Given the limited evidence identified, the authors' cautious conclusions are likely to be reliable. Authors' objectives To assess the efficacy of a palliative care model in patients with dementia. Searching MEDLINE, EMBASE, PsycINFO, CINAHL, the British Nursing Index, AMED, Web of Science and SIGLE were searched from inception to October 2003. The third quarter of the Cochrane Database

2005 DARE.

605. Effect of individualized social activity on sleep in nursing home residents with dementia

Effect of individualized social activity on sleep in nursing home residents with dementia Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2005 NHS Economic Evaluation Database.

606. Mixed dementia: emerging concepts and therapeutic implications. Full Text available with Trip Pro

Mixed dementia: emerging concepts and therapeutic implications. The prevalence of mixed dementia, defined as the coexistence of Alzheimer disease (AD) and vascular dementia (VaD), is likely to increase as the population ages.To provide an overview of the diagnosis, pathophysiology, and interaction of AD and VaD in mixed dementia, and to provide a systematic literature review of the current evidence for the pharmacologic therapy of mixed dementia.The Cochrane Database of Systematic Reviews (...) was searched using the keyword dementia. MEDLINE was searched for English-language articles published within the last 10 years using the keywords mixed dementia, the combination of keywords Alzheimer disease, cerebrovascular disorders, and drug therapy, and the combination of keywords vascular dementia and drug therapy.Dementia is more likely to be present when vascular and AD lesions coexist, a situation that is especially common with increasing age. The measured benefits in clinical trials

2004 JAMA

607. A multifactorial intervention after a fall did not prevent falls in elderly patients with cognitive impairment and dementia Full Text available with Trip Pro

A multifactorial intervention after a fall did not prevent falls in elderly patients with cognitive impairment and dementia A multifactorial intervention after a fall did not prevent falls in elderly patients with cognitive impairment and dementia | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using (...) your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here A multifactorial intervention after a fall did not prevent falls in elderly patients with cognitive impairment and dementia Article Text

2004 Evidence-Based Nursing

608. Oestrogen plus progestin doubles the risk of dementia in post-menopausal women Full Text available with Trip Pro

Oestrogen plus progestin doubles the risk of dementia in post-menopausal women Oestrogen plus progestin doubles the risk of dementia in post-menopausal women | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts (...) Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Oestrogen plus progestin doubles the risk of dementia in post-menopausal women Article Text Therapeutics Oestrogen plus progestin doubles the risk of dementia in post-menopausal women Free Barbara B Sherwin , PhD , Professor , James

2004 Evidence-Based Mental Health

609. Insufficient evidence on benefits of early detection and treatment of dementia Full Text available with Trip Pro

Insufficient evidence on benefits of early detection and treatment of dementia Insufficient evidence on benefits of early detection and treatment of dementia | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts (...) Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Insufficient evidence on benefits of early detection and treatment of dementia Article Text Diagnosis Insufficient evidence on benefits of early detection and treatment of dementia Free James P Warner , MD MRCPsych Statistics from

2004 Evidence-Based Mental Health

610. Oestrogen plus progestin increased risk of stroke and probable dementia in postmenopausal women Full Text available with Trip Pro

Oestrogen plus progestin increased risk of stroke and probable dementia in postmenopausal women Oestrogen plus progestin increased risk of stroke and probable dementia in postmenopausal women | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts (...) OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Oestrogen plus progestin increased risk of stroke and probable dementia in postmenopausal women Article Text Therapeutics Oestrogen plus progestin increased risk of stroke and probable dementia

2004 Evidence-Based Medicine

611. Zhiling decoction for vascular dementia. (Abstract)

Zhiling decoction for vascular dementia. Zhiling decoction has a fixed composition of 15 Chinese herbs. The properties of each of these herbs and in combination provide the therapeutic rationale for a possible action of Zhiling decoction in dilating cerebral vessels and increasing cerebral blood flow, as well as reducing serum cholesterol. Thus the aim of this review is to evaluate efficacy and safety of Zhiling decoction for the treatment of vascular dementia.To assess the efficacy and safety (...) of Zhiling decoction for vascular dementia.The Specialized Register of the Cochrane Dementia and Cognitive Improvement Group was searched on 2 January 2004 using the term Zhiling. This Register contains records from all major health care databases and many ongoing trials databases and is updated regularly. In addition the reviewers hand searched 83 Chinese Traditional Medicine Journals (1993 to 2003).Randomised trials comparing Zhiling decoction with placebo in people with vascular dementia.Two reviewers

2004 Cochrane

612. Trazodone for agitation in dementia. Full Text available with Trip Pro

Trazodone for agitation in dementia. Behavioural and psychiatric disturbances affect at least 50% of people with Alzheimer's disease and other dementias. Neuroleptic drugs are extensively prescribed to treat behavioural manifestations of dementia in spite of only modest efficacy and a high frequency of adverse effects. There is clearly a need for safer and more effective remedies. Trazodone is a psychoactive compound with sedative and antidepressant properties, and with mixed serotonin agonist (...) and antagonist effects. Functional serotonergic deficits may be related to the genesis of behavioural disturbances in dementia.To determine the clinical efficacy and safety of trazodone, for any type of behavioural or psychological cognition in people with dementia without an additional diagnosis of depression.Trials were identified from a search of the Specialized Register of the Cochrane Dementia and Cognitive Improvement Group on 1 June 2004 using the terms trazodon*, beneficat, desirel, sideril, trazodil

2004 Cochrane

613. Walking and dementia in physically capable elderly men. Full Text available with Trip Pro

Walking and dementia in physically capable elderly men. Evidence suggests that physical activity may be related to the clinical expression of dementia. Whether the association includes low-intensity activity such as walking is not known.To examine the association between walking and future risk of dementia in older men.Prospective cohort study.Distance walked per day was assessed from 1991 to 1993 in 2257 physically capable men aged 71 to 93 years in the Honolulu-Asia Aging Study. Follow-up (...) for incident dementia was based on neurological assessment at 2 repeat examinations (1994-1996 and 1997-1999).Overall dementia, Alzheimer disease, and vascular dementia.During the course of follow-up, 158 cases of dementia were identified (15.6/1000 person-years). After adjusting for age, men who walked the least (<0.25 mile/d) experienced a 1.8-fold excess risk of dementia compared with those who walked more than 2 mile/d (17.8 vs 10.3/1000 person-years; relative hazard [RH], 1.77; 95% confidence interval

2004 JAMA

614. Addressing the ethical, legal, and social issues raised by voting by persons with dementia. Full Text available with Trip Pro

Addressing the ethical, legal, and social issues raised by voting by persons with dementia. This article addresses an emerging policy problem in the United States participation in the electoral process by citizens with dementia. At present, health care professionals, family caregivers, and long-term care staff lack adequate guidance to decide whether individuals with dementia should be precluded from or assisted in casting a ballot. Voting by persons with dementia raises a series of important (...) questions about the autonomy of individuals with dementia, the integrity of the electoral process, and the prevention of fraud. Three subsidiary issues warrant special attention: development of a method to assess capacity to vote; identification of appropriate kinds of assistance to enable persons with cognitive impairment to vote; and formulation of uniform and workable policies for voting in long-term care settings. In some instances, extrapolation from existing policies and research permits

2004 JAMA

615. Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study. Full Text available with Trip Pro

Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study. To evaluate the relation between midlife alcohol consumption and mild cognitive impairment and dementia in old age, and the possible modification of this relation by apolipoprotein E.Prospective, population based study.Populations of Kuopio and Joensuu, eastern Finland.Of 1464 men and women aged 65-79 years randomly selected from population based samples (...) studied in 1972 or 1977, 1018 (70%) were re-examined in 1998 (after an average follow up of 23 years).Mild cognitive impairment and dementia in old age.Participants who drank no alcohol at midlife and those who drank alcohol frequently were both twice as likely to have mild cognitive impairment in old age as those participants who drank alcohol infrequently. The risk of dementia related to alcohol drinking was modified by the presence of the apolipoprotein e4 allele. The carriers of apolipoprotein e4

2004 BMJ

616. Using rapid-cycle quality improvement methodology to reduce feeding tubes in patients with advanced dementia: before and after study. Full Text available with Trip Pro

Using rapid-cycle quality improvement methodology to reduce feeding tubes in patients with advanced dementia: before and after study. Despite lack of evidence that enteral feeding tubes benefit patients with dementia, and often contrary to the wishes of patient and family, patients with dementia who have difficulty swallowing or reduced food intake often receive feeding tubes when hospitalised for an acute illness.We conducted a retrospective chart review of all patients receiving percutaneous (...) endoscopic gastrostomy or jejunostomy tubes between March and September 2002. QI interventions including a palliative care consulting service and educational programmes were instituted. We conducted a second chart review for all patients receiving feeding tubes between March and September 2003.652 bed urban acute care hospital.We measured the number of feeding tubes placed in patients with dementia, the number of feeding tubes placed in patients with dementia capable of taking food by mouth

2004 BMJ

617. Long-term care placement of dementia patients and caregiver health and well-being. Full Text available with Trip Pro

Long-term care placement of dementia patients and caregiver health and well-being. Placing a relative with dementia into a long-term care facility is common among caregivers. Placement transition and factors that affect caregiver health and well-being after placement of the patient are not well described.To assess the impact of placing a relative with dementia in a long-term care facility on caregivers' health and well-being.Prospective study from 1996 to 2000 of the placement transition (...) in a sample of 1222 caregiver-patient dyads recruited from 6 US sites. A total of 180 patients were placed in a long-term care facility during the 18-month follow-up period. Data collected before and after placement were analyzed to identify factors associated with placement, the nature of contact between caregivers and their institutionalized relatives after placement, and the relation of both of these factors to health outcomes among dementia caregivers.Caregiver depression (symptoms on the Center

2004 JAMA

618. Estimating prognosis for nursing home residents with advanced dementia. Full Text available with Trip Pro

Estimating prognosis for nursing home residents with advanced dementia. Survival varies for patients with advanced dementia, and accurate prognostic tools have not been developed. A small proportion of patients admitted to hospice have dementia, in part because of the difficulty in predicting survival.To identify factors associated with 6-month mortality in newly admitted nursing home residents with advanced dementia and to create a practical risk score to predict 6-month mortality (...) in this population.This was a retrospective cohort study of data from the Minimum Data Set (MDS). All Medicare or Medicaid licensed nursing homes in New York and Michigan were included. Participants had advanced dementia and were admitted to New York nursing homes between June 1, 1994, and December 30, 1998 (derivation cohort, n = 6799), and to Michigan nursing homes from October 1, 1998, through July 30, 2000 (validation cohort, n = 4631).MDS factors associated with 6-month mortality were determined

2004 JAMA

619. Caregiving strategies for older adults with delirium, dementia and depression.

Caregiving strategies for older adults with delirium, dementia and depression. Guidelines and Measures | Agency for Healthcare Research & Quality HHS.gov Search ahrq.gov Search ahrq.gov Menu Topics A - Z Healthcare Delivery Latest available findings on quality of and access to health care Searchable database of AHRQ Grants, Working Papers & HHS Recovery Act Projects AHRQ Projects funded by the Patient-Centered Outcomes Research Trust Fund You are here Guidelines and Measures Funding

2004 Registered Nurses' Association of Ontario

620. Alpha lipoic acid for dementia. (Abstract)

Alpha lipoic acid for dementia. Oxidative processes have been implicated in the pathogenesis of neurodegenerative dementias including Alzheimer's disease. Protecting the central nervous system against these damaging mechanisms may be a useful therapeutic approach. Alpha lipoic acid (ALA) is an endogenous antioxidant that interrupts cellular oxidative processes in both its oxidized and reduced forms. These properties might qualify ALA for a modulatory role in the treatment of people (...) with dementia.To assess the role and clinical efficacy of alpha lipoic acid in the treatment of dementia.A search of the Specialized Register of the Cochrane Dementia and Cognitive Improvement Group (CDCIG) on 3 February 2003 using the terms 'alpha lipoic acid' and 'thioctic'. The CDCIG Specialized register is updated regularly and contains records from all major health care databases (MEDLINE, EMBASE, PsycInfo, CINAHL) as well as from many trials databases.All double-blind randomized placebo-controlled trials

2004 Cochrane